Yara International ASA
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YRAIF research report →
Price Chart
About the company
Yara International ASA is a global entity providing environmental and industrial solutions across a wide geographical spread, including Norway, the European Union, the broader European continent, Africa, Asia, North and Latin America, Australia, and New Zealand. The company's core business revolves around a diverse portfolio of plant nutrition products. This includes various nitrogen-based fertilizers such as urea, urea ammonium nitrate (UAN), calcium ammonium nitrate (CAN), ammonium nitrate (AN), and ammonium sulfate.
- CEO
- Svein Tore Holsether
- IPO
- 2004
- Employees
- 15,702
- HQ
- Oslo, PS, NO
Get TickerSpark's AI analysis on YRAIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.60B
- P/E
- 7.70
- Fwd P/E
- 7.49
- PEG
- 0.06
- P/S
- 0.71
- P/B
- 1.31
- EV/EBITDA
- 4.39
- Div Yield
- 5.08%
- Gross Margin
- 26.26%
- Op Margin
- 12.49%
- Net Margin
- 9.25%
- ROE
- 17.43%
- ROIC
- 11.59%
Latest fiscal year · YoY change
- Revenue
- $15.62B+13.2%
- Gross Profit
- $4.42B+20.2%
- Op Income
- $1.59B
- Net Income
- $1.41B+9958.4%
- EPS
- $5.37+9663.6%
- OCF Growth
- +47.3%
- FCF Growth
- +285.5%
- 52W High
- $59.85
- 52W Low
- $35.62
- 50D MA
- $47.24
- 200D MA
- $46.80
- Beta
- 0.23
- RSI (14)
- 17
- Avg Volume
- 62
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Yara reported a strong second quarter with EBITDA up 39% year over year, but results were shaped by demand deferral, lower deliveries, and unusually volatile nitrogen markets.· July 17, 2026
- EBITDA excluding special items was $906 million, up 39% year over year and the highest quarterly EBITDA in a decade except 2022.
- Earnings per share rose 84%, and return on invested capital increased to 14.3% from 7% a year ago.
- Crop nutrition deliveries were 17% below the same quarter last year as buyers deferred purchases amid sharp price spikes and market uncertainty.
- Yara sold 1.7 million surplus EUA quotas, booking a $153 million gain as a special item.
- The Gulf Coast Ammonia acquisition in Texas is a major strategic move that management says improves ammonia cost position, flexibility, and long-term returns.
Yara reported second-quarter EBITDA excluding special items of $906 million, up 39% year over year, driven mainly by higher nitrogen margins. EPS increased 84%, and ROIC was 14.3% versus 7% last year; the quarter also included a $153 million gain from the sale of surplus EUA quotas as a special item. Crop nutrition deliveries were 17% below the same quarter last year, with management citing a $240 million negative volume impact and $120 million from demand deferral. Free cash flow for the quarter was $583 million, net investments were $100 million, and net debt stayed relatively stable despite the dividend. For the next quarter, management did not give formal financial guidance, but said Q3 should see improved demand as buying activity has resurfaced, while Pilbara is scheduled for about a month of maintenance and market uncertainty remains elevated.
Svein Tore Holsether emphasized safety, saying accident trends had worsened again and that Yara is working to bring TRI down to zero. Strategically, he framed the quarter as proof of strong underlying margins and disciplined capital allocation, while noting that demand was deferred into Q3 because customers avoided buying at peak prices. He highlighted the Gulf Coast Ammonia acquisition as a major milestone that strengthens Yara’s cost position, expands flexibility, and fits its returns-focused framework.
Magnus Krogh Ankarstrand said the EBITDA increase was predominantly driven by improved nitrogen upstream margins and that EPS rose 84% on a stable capital base. He explained that cash from operations was affected by a small working-capital buildup because the seasonal pickup was delayed, while free cash flow still reached $583 million and net debt remained stable. He also noted that fixed costs rose only $8 million quarter over quarter, below the roughly $35 million inflation estimate, and that currency added about $65 million over the last 12 months. On capital allocation, he said the EUA sale was a financial decision to reduce a long position, not speculation, and that the GCA deal should improve the cost curve and energy exposure while preserving balance-sheet strength.
Analysts focused on the gap between reported margins and outside-in models, the shortfall in Q3 pricing assumptions, the rationale for selling EUA credits, and the impact of turnarounds and inventories on earnings sensitivity. Management said the main margin miss was explained by volume timing and the fact that weekly price references can differ sharply from actual realized volumes in a volatile quarter. On EUAs, they said the sale was mainly to lower a long position and manage risk, while CCS at Sluiskil means the surplus remains substantial even after the sale. They also said Pilbara will be down for about a month in Q3 and that they would not recommend changing the usual pricing lag assumption materially.
The call pointed to strong pricing, with nitrogen margins expanding and global prices rebounding in recent days, especially as Europe began to pre-buy for the next season again. Management said the business is generating strong cash flow, improving asset utilization, and progressing on an EBITDA improvement program that has already realized $560 million of the 2027 target. The GCA acquisition was presented as an attractive, disciplined step that should improve cost position and flexibility.
The main downside was demand deferral and lower deliveries, especially in Europe, after prices spiked and buyers waited out the peak. Management also flagged ongoing volatility and geopolitical risk in the Middle East, plus Pilbara reliability issues and scheduled maintenance that will affect Q3 volumes. Analysts pressed on whether some of the weakness was demand destruction rather than only deferral, and management acknowledged that some demand was rationed away during the quarter.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 63.8%
- Shares Outstanding
- 254.73M
- Float Shares
- 162.48M
Our YRAIF coverage
Recent articles, reports, and earnings notes.
No research on YRAIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate YRAIF report →